A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)

被引：0
|
作者：
A Bensalem
K Bouzid
机构：
[1] Chu Dr Benbardis,Medical Oncology
来源：
Breast Cancer Research | / 7卷
关键词：
Breast Cancer; Doxorubicin; Neutropenia; Gemcitabine; Partial Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] A phase II trial of vinorelbine and pegylated liposomal doxorubicin in patients with pretreated metastatic breast cancer
    Chow, Louis Wing-Cheong
    Yip, Adrian Yun-San
    Lang, Brian Hung-Hin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (02): : 133 - 138
  • [32] A Phase II randomized trial of pembrolizumab with carboplatin and gemcitabine for treatment of patients with metastatic triple-negative breast cancer (mTNBC)
    Obeid, E.
    Miller, K. D.
    Sparano, J. A.
    Blackwell, K.
    Goldstein, L. J.
    CANCER RESEARCH, 2017, 77
  • [33] Phase II study of gemcitabine and cisplatin in women with taxane-failed metastatic breast cancer (MBC)
    Wang, T.
    Jiang, Z.
    Song, S.
    Shen, G.
    Zhang, S.
    Wu, S.
    Zeng, M.
    EJC SUPPLEMENTS, 2005, 3 (02): : 127 - 127
  • [34] A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
    Tomao, Silverio
    Romiti, Adriana
    Tomao, Federica
    Di Seri, Marisa
    Caprio, Giuliana
    Spinelli, Gian Paolo
    Terzoli, Edmondo
    Frati, Luigi
    BMC CANCER, 2006, 6 (1)
  • [35] Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: A phase II trial
    Laufman, LR
    Spiridonidis, CH
    Pritchard, J
    Roach, R
    Zangmeister, J
    Larrimer, N
    Moore, T
    Segal, M
    Jones, J
    Patel, T
    Gutterman, L
    Carman, L
    Colborn, D
    Kuebler, JP
    ANNALS OF ONCOLOGY, 2001, 12 (09) : 1259 - 1264
  • [36] A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
    Silverio Tomao
    Adriana Romiti
    Federica Tomao
    Marisa Di Seri
    Giuliana Caprio
    Gian Paolo Spinelli
    Edmondo Terzoli
    Luigi Frati
    BMC Cancer, 6
  • [37] PHASE-II TRIAL OF DOXORUBICIN AND TRIFLUOPERAZINE IN METASTATIC BREAST-CANCER
    BUDD, GT
    BUKOWSKI, RM
    LICHTIN, A
    BAUER, L
    VANKIRK, P
    GANAPATHI, R
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (01) : 75 - 79
  • [38] A phase II trial of a histamine antagonist (DPPE) and doxorubicin in metastatic breast cancer
    de Boer R.
    Breast Cancer Research, 2 (1)
  • [39] Phase II clinical trial of ixabepilone in metastatic breast cancer (MBC) patients previously untreated with taxanes.
    Denduluri, N.
    Lee, J. J.
    Walshe, J. M.
    Yang, S. X.
    Vatas, U.
    Chow, C. K.
    Steinberg, S. M.
    Cox, M. C.
    Low, J. A.
    Swain, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 40S - 40S
  • [40] Gemcitabine (G) and cisplatin (C) as first-line treatment of metastatic breast cancer (MBC): Results of phase II trial.
    Karthaus, M.
    Poddubnaya, I.
    Churilova, L.
    Khasanov, R.
    Veremeychuk, T.
    Rumyantseva, E.
    Garin, M.
    Brichkova, O.
    Heinrich, B.
    Heinemann, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
12345